Dr. Maha Radhakrishnan, former Biogen CMO, joined Sofinnova Investments this week as Executive Partner
She describes why she decided to move to the investment side and Sofinnova, what areas of science interest her today, and some thoughts on the Alzheimer's space given her experience at Biogen.